Uploaded April 2026 | Updated September 2026, 1 day ago
Mikkael Sekeres, MD, MS, explains Low-Risk MDS, or Myelodysplastic Syndromes, in this session. This presentation reveals answers to most questions that patients and families have.
#MDS #myelodysplasia #bloodcancer
If this presentation was useful to you, you may also like to watch:
"Living with Low-Risk MDS from the 2022 Buffalo Patient and Family Hybrid Conference" aamds.org/webinar/living-low-risk-mds-2022-buffalo-patient-and-family-hybrid-conference
or
"Updates in MDS Treatment and Research from ASCO and EHA Meetings 2022" aamds.org/webinar/updates-mds-treatment-and-research-asco-and-eha-meetings-2022
Mikkael Sekeres, MD, MS, explains Low-Risk MDS, or Myelodysplastic Syndromes, in this session. This presentation reveals answers to most questions that patients and families have.
#MDS #myelodysplasia #bloodcancer
If this presentation was useful to you, you may also like to watch:
"Living with Low-Risk MDS from the 2022 Buffalo Patient and Family Hybrid Conference" aamds.org/webinar/living-low-risk-mds-2022-buffalo-patient-and-family-hybrid-conference
or
"Updates in MDS Treatment and Research from ASCO and EHA Meetings 2022" aamds.org/webinar/updates-mds-treatment-and-research-asco-and-eha-meetings-2022










